Study Confirms Anti-inflammatory and Other Properties of CBD
Filed with ASX · · 5 pages · English
Watch Botanix Pharmaceuticals' latest callBotanix Pharmaceuticals (ASX:BOT) Q2 2026 Earnings Call · Replay · Mar 2Read the transcript of Botanix Pharmaceuticals (ASX:BOT) Q2 2026 Earnings CallBotanix Pharmaceuticals Limited on 6ix
In the deck
Story so far
Earlier from Botanix Pharmaceuticals
- Pause in Trade
- Dermatology Industry Leader Joins Botanix
- Botanix Provides Retraction in Presentation
- Pause In Trading
- Permetrex Outperforms Other CBD Topical Products
Later from Botanix Pharmaceuticals
- BTX 1801 Kills Superbugs Without Resistance World-First
- Botanix Antimicrobial Platform Addresses Global Threat
- Botanix $40 Million US Lead Placement and Management Update
- Appendix 4E and Annual Report
- Botanix announces new clinical program to target rosacea
Follow Botanix Pharmaceuticals into a list and get an email when it puts out news.
Follow Botanix Pharmaceuticals